Nichi-Iko Pharmaceutical: Nichi Iko Pharmaceutical : DelayedConsolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2022 (IFRS)
(marketscreener.com) Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2022 Company name: Nichi-Iko Pharmaceutical Co., Ltd. ...https://www.marketscreener.com/quote/stock/NICHI-IKO-PHARMACEUTICAL-6814872/news/Nichi-Iko-Pharmaceutical-12308-Delayed-12309-Consolidated-Financial-Results-for-the-First-Quart-36353431/?utm_medium=RSS&utm_content=20210906
Read full article »
President & CEO
Yuichi Tamura
Nichi-Iko Pharmaceutical engages in manufacturing and commercializing prescription drugs issued by hospitals, clinics, pharmacies and drug stores.
Read more